A citation-based method for searching scientific literature

Fatemeh Ghorbani Parsa, Stefania Nobili, Mina Karimpour, Hamid Asadzadeh Aghdaei, Ehsan Nazemalhosseini-Mojarad, Enrico Mini. J Pers Med 2022
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The Interleukin 22 Pathway Interacts with Mutant KRAS to Promote Poor Prognosis in Colon Cancer.
Sarah McCuaig, David Barras, Elizabeth H Mann, Matthias Friedrich, Samuel J Bullers, Alina Janney, Lucy C Garner, Enric Domingo, Viktor Hendrik Koelzer, Mauro Delorenzi,[...]. Clin Cancer Res 2020
13
100

The role of Hypoxia-Inducible Factor-1alpha and its signaling in melanoma.
Mohammad Malekan, Mohammad Ali Ebrahimzadeh, Fateme Sheida. Biomed Pharmacother 2021
14
100

JAK-STAT Signalling Pathway in Cancer.
Andrew J Brooks, Tracy Putoczki. Cancers (Basel) 2020
25
100


IL-10 and IL-22 in Mucosal Immunity: Driving Protection and Pathology.
Hua-Xing Wei, Baolong Wang, Bofeng Li. Front Immunol 2020
40
100

IL22 furthers malignant transformation of rat mesenchymal stem cells, possibly in association with IL22RA1/STAT3 signaling.
Xiangrong Cui, Xuan Jing, Qin Yi, Zhongping Xiang, Jie Tian, Bin Tan, Jing Zhu. Oncol Rep 2019
13
100

TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells.
Taiwen Li, Jingyu Fan, Binbin Wang, Nicole Traugh, Qianming Chen, Jun S Liu, Bo Li, X Shirley Liu. Cancer Res 2017
100

TSLP: from allergy to cancer.
Jonathan Corren, Steven F Ziegler. Nat Immunol 2019
76
100

Fanconi anemia pathway as a prospective target for cancer intervention.
Wenjun Liu, Anna Palovcak, Fang Li, Alyan Zafar, Fenghua Yuan, Yanbin Zhang. Cell Biosci 2020
25
100

IL22RA1/STAT3 Signaling Promotes Stemness and Tumorigenicity in Pancreatic Cancer.
Weizhi He, Jinghua Wu, Juanjuan Shi, Yan-Miao Huo, Wentao Dai, Jing Geng, Ping Lu, Min-Wei Yang, Yuan Fang, Wei Wang,[...]. Cancer Res 2018
63
100

TYK2: An Upstream Kinase of STATs in Cancer.
Katharina Wöss, Natalija Simonović, Birgit Strobl, Sabine Macho-Maschler, Mathias Müller. Cancers (Basel) 2019
29
100

IL-22(+)CD4(+) T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1L.
Ilona Kryczek, Yanwei Lin, Nisha Nagarsheth, Dongjun Peng, Lili Zhao, Ende Zhao, Linda Vatan, Wojciech Szeliga, Yali Dou, Scott Owens,[...]. Immunity 2014
246
100

Thymic stromal lymphopoietin and cancer.
Emma Lo Kuan, Steven F Ziegler. J Immunol 2014
39
100

Identification of IL20RB as a Novel Prognostic and Therapeutic Biomarker in Clear Cell Renal Cell Carcinoma.
Hongda Guo, Songlin Jiang, Haoyu Sun, Benkang Shi, Yan Li, Nan Zhou, Dongqing Zhang, Hu Guo. Dis Markers 2022
3
100

The role of the IL-22/IL-22R1 axis in cancer.
Chrissie Lim, Ram Savan. Cytokine Growth Factor Rev 2014
119
100

TYK2 in Cancer Metastases: Genomic and Proteomic Discovery.
Dana C Borcherding, Kevin He, Neha V Amin, Angela C Hirbe. Cancers (Basel) 2021
7
100

Estimating the predictive power of silent mutations on cancer classification and prognosis.
Tal Gutman, Guy Goren, Omri Efroni, Tamir Tuller. NPJ Genom Med 2021
5
100

The role of JAK/STAT signaling pathway and its inhibitors in diseases.
Ping Xin, Xiaoyun Xu, Chengjie Deng, Shuang Liu, Youzhi Wang, Xuegang Zhou, Hongxing Ma, Donghua Wei, Shiqin Sun. Int Immunopharmacol 2020
160
100

TIMER2.0 for analysis of tumor-infiltrating immune cells.
Taiwen Li, Jingxin Fu, Zexian Zeng, David Cohen, Jing Li, Qianming Chen, Bo Li, X Shirley Liu. Nucleic Acids Res 2020
100

Establishing the role of tyrosine kinase 2 in cancer.
Caroline Ubel, Stephanie Mousset, Denis Trufa, Horia Sirbu, Susetta Finotto. Oncoimmunology 2013
23
100

Interleukin-22: immunobiology and pathology.
Jarrod A Dudakov, Alan M Hanash, Marcel R M van den Brink. Annu Rev Immunol 2015
486
100

Cytokine Signaling in Tumor Progression.
Myungmi Lee, Inmoo Rhee. Immune Netw 2017
43
100

High IL-22RA1 gene expression is associated with poor outcome in muscle invasive bladder cancer.
Katja Nitschke, Thomas S Worst, Sophie Madeleine von Rhade, Blerta Thaqi, Manuel Neuberger, Frederik Wessels, Cleo-Aron Weis, Stefan Porubsky, Timo Gaiser, Maximilian Kriegmair,[...]. Urol Oncol 2021
1
100

JAK/STAT signalling pathway in colorectal cancer: a new biological target with therapeutic implications.
Jean-Philippe Spano, Gerard Milano, Clivier Rixe, Remi Fagard. Eur J Cancer 2006
58
100

A novel role for IL-22R1 as a driver of inflammation.
Ram Savan, Adelle P McFarland, Della A Reynolds, Lionel Feigenbaum, Karthika Ramakrishnan, Megan Karwan, Hidekazu Shirota, Dennis M Klinman, Kieron Dunleavy, Stefania Pittaluga,[...]. Blood 2011
52
100

Comprehensive analysis of competitive endogenous RNA associated with immune infiltration in lung adenocarcinoma.
Wenjie Chen, Wen Li, Zhenkun Liu, Guangzhi Ma, Yunfu Deng, Xiaogang Li, Zhu Wang, Qinghua Zhou. Sci Rep 2021
3
100


Normal Somatic Mutations in Cancer Transformation.
Neshika Wijewardhane, Lisa Dressler, Francesca D Ciccarelli. Cancer Cell 2021
19
100

Salmonella Breaks Tumor Immune Tolerance by Downregulating Tumor Programmed Death-Ligand 1 Expression.
Man-Chin Chen, Christian Ronquillo Pangilinan, Che-Hsin Lee. Cancers (Basel) 2019
13
100

IL10R2 Overexpression Promotes IL22/STAT3 Signaling in Colorectal Carcinogenesis.
Vineeta Khare, Gregor Paul, Oliver Movadat, Adrian Frick, Manuela Jambrich, Anita Krnjic, Brigitte Marian, Friedrich Wrba, Christoph Gasche. Cancer Immunol Res 2015
25
100

9
100

IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis.
Malcolm R Starkey, Maximilian W Plank, Paolo Casolari, Alberto Papi, Stelios Pavlidis, Yike Guo, Guy J M Cameron, Tatt Jhong Haw, Anthony Tam, Ma'en Obiedat,[...]. Eur Respir J 2019
34
100


Critical Role of IL-22/IL22-RA1 Signaling in Pneumococcal Pneumonia.
Giraldina Trevejo-Nunez, Waleed Elsegeiny, Parker Conboy, Kong Chen, Jay K Kolls. J Immunol 2016
37
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.